-
Validation of a Flexible Partitioned Survival and 3-State Markov Model for Cost-Effectiveness Analyses in Oncology
Mar 10, 2025, 14:00 PM -
Dupilumab Improves Health-Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease and Type 2 Inflammation: Results From the BOREAS and NOTUS Trials
Mar 10, 2025, 14:00 PM -
Real-World (rw) Early Clinical Endpoints for Patients with Resectable Non-Small Cell Lung Cancer (NSCLC): A Database Evaluation Study
Mar 10, 2025, 14:00 PM -
Validation of Real-World Pathologic Complete Response in Early Stage Triple Negative Breast Cancer
Mar 10, 2025, 14:00 PM -
Surgical Stripping and Ligation Compared to Cyanoacrylate Vein Closure in the Mexican Public Healthcare Setting: Direct Costs and Incapacity Pay
Mar 10, 2025, 14:00 PM -
Ferric Derisomaltose for the Treatment of Iron Deficiency Anemia: A Real-World Evidence Study
Mar 10, 2025, 14:00 PM -
Transforming Global Value Dossier (GVD) Drafting: Creation with a Generative Artificial Intelligence (Gen AI)-Driven Coauthoring Accelerator
Mar 10, 2025, 14:00 PM -
Digital Health Interventions and Environmental Sustainability: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Choosing Wisely?' Use of Staging Imaging in US Veteran Patients With Prostate Cancer
Mar 10, 2025, 14:00 PM -
Assessment of Artificial Intelligence-Enabled Health Technologies: Our Initial Experience at Canada's Drug Agency
Mar 10, 2025, 14:00 PM -
Physician, Patient and Caregiver Concordance in a Real-World US Generalized Myasthenia Gravis Population
Mar 10, 2025, 14:00 PM -
Innovative Strategy for Resistant Depression and Suicidal Ideation: HEOR Analysis From the Perspective of BRAZIL / LATAM / LMIC .
Mar 10, 2025, 14:00 PM -
Preparing for German Health Technology Assessment: Analysis of Factors Associated with the Risk of Having Inappropriate Comparator
Mar 10, 2025, 14:00 PM -
Racial and Health Insurance Status Disparities in the Use of Percutaneous Vertebral Augmentation and Healthcare Utilization for Osteoporotic Vertebral Fractures: A Retrospective Observational Analysis
Mar 10, 2025, 14:00 PM -
Molecular Profiling, Treatment (Tx) Patterns, and Healthcare Resource Utilization (HCRU) in United States Patients with Unresectable Locally Advanced/Metastatic Biliary Tract Cancer
Mar 10, 2025, 14:00 PM -
The Blinded Economic Impact of Chemotherapy: How Adverse Effects Affect Costs During Bladder Oncology Treatments
Mar 10, 2025, 14:00 PM -
Real-World Impact Of Recurrence On Overall Survival (OS) In Patients With Unresectable Locally Advanced (LA) Esophageal/Gastroesophageal Junction Cancer (EC/GEJC) Treated With Definitive Chemoradiotherapy (dCRT) In US Community Oncology Clinics
Mar 10, 2025, 14:00 PM -
Study on Online Tools of Pharmacoeconomic Model Construction and Value Communication
Mar 10, 2025, 14:00 PM -
Frequently Asked Questions (FAQs): What Are the Risks and Mitigation Strategies in Using Gen-AI in HEOR?
Mar 10, 2025, 14:00 PM -
Mapping the HAQ-DI to the EQ-5D-5L and SF-6Dv2 Among Chinese Patients With Gout
Mar 10, 2025, 14:00 PM
